Dynamic Advisor Solutions LLC decreased its position in CVS Health Corp (NYSE:CVS) by 69.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,800 shares of the pharmacy operator’s stock after selling 22,322 shares during the quarter. Dynamic Advisor Solutions LLC’s holdings in CVS Health were worth $641,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bell Rock Capital LLC grew its position in CVS Health by 764.0% during the fourth quarter. Bell Rock Capital LLC now owns 432 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 382 shares during the period. Daiwa SB Investments Ltd. bought a new position in CVS Health during the fourth quarter valued at about $30,000. Cornerstone Advisors Inc. grew its position in CVS Health by 71.6% during the third quarter. Cornerstone Advisors Inc. now owns 508 shares of the pharmacy operator’s stock valued at $40,000 after buying an additional 212 shares during the period. Avestar Capital LLC grew its position in CVS Health by 19.6% during the fourth quarter. Avestar Capital LLC now owns 951 shares of the pharmacy operator’s stock valued at $57,000 after buying an additional 156 shares during the period. Finally, Truewealth LLC grew its position in CVS Health by 78.6% during the fourth quarter. Truewealth LLC now owns 1,004 shares of the pharmacy operator’s stock valued at $66,000 after buying an additional 442 shares during the period. Hedge funds and other institutional investors own 87.22% of the company’s stock.
In other news, COO Jonathan C. Roberts sold 77,639 shares of the stock in a transaction dated Friday, February 1st. The shares were sold at an average price of $64.54, for a total value of $5,010,821.06. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Larry J. Merlo sold 166,368 shares of the stock in a transaction dated Tuesday, January 8th. The stock was sold at an average price of $69.04, for a total transaction of $11,486,046.72. Following the completion of the sale, the insider now directly owns 496,577 shares in the company, valued at $34,283,676.08. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 435,534 shares of company stock worth $29,245,258. Insiders own 0.53% of the company’s stock.
Several equities analysts recently weighed in on the stock. ValuEngine lowered shares of CVS Health from a “sell” rating to a “strong sell” rating in a research report on Saturday, February 2nd. UBS Group assumed coverage on shares of CVS Health in a research report on Thursday, January 17th. They set a “buy” rating and a $75.00 price target for the company. Cantor Fitzgerald restated a “buy” rating and set a $96.00 price target on shares of CVS Health in a research report on Thursday, January 3rd. Bank of America restated a “buy” rating and set a $92.00 price target on shares of CVS Health in a research report on Thursday, January 3rd. Finally, Barclays assumed coverage on shares of CVS Health in a research report on Tuesday, December 18th. They set an “overweight” rating and a $91.00 price target for the company. One analyst has rated the stock with a sell rating, two have given a hold rating and thirteen have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $91.79.
NYSE CVS opened at $67.79 on Thursday. The stock has a market cap of $66.34 billion, a price-to-earnings ratio of 11.49, a price-to-earnings-growth ratio of 0.88 and a beta of 1.03. CVS Health Corp has a 52 week low of $60.14 and a 52 week high of $82.15. The company has a current ratio of 2.44, a quick ratio of 1.94 and a debt-to-equity ratio of 1.66.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 4th. Shareholders of record on Friday, January 25th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.95%. The ex-dividend date was Thursday, January 24th. CVS Health’s dividend payout ratio (DPR) is presently 33.90%.
ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Stock Observer and is the property of of Stock Observer. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://www.thestockobserver.com/2019/02/14/cvs-health-corp-cvs-stake-lessened-by-dynamic-advisor-solutions-llc.html.
About CVS Health
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Further Reading: Determine Your Level of Risk Tolerance
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.